Biotech and pharma
Cisiv has been serving the life science and biotech industry for 15 years.
At its origins, a top tier pharma company (J&J) was planning a large health outcomes study and was unimpressed by the market’s EDC offerings which were designed around clinical trial processes rather than investigations of late phase data. They asked Cisiv to build a web-based study platform specifically around prospective observational research. This developed into the pharma company’s largest and most successful ever web-based study, spanning 19 countries and 8 languages (e-Star). It ran for 10 years, enrolled 20,000 patients and supported hundreds of publications, HTA and reimbursement processes.
Our fully integrated platform of modules provides end-to-end capabilities and include: eConsent/eAssent, medical release at site or remotely, eCOA to collect direct from patients and carers on mobile app or web, eDiaries, surveys, and is fully compliant with global regulations.
The fit-for-purpose technology means that we can help cut 60% of data management costs.
Types of research we enable:
- Registries and pregnancy registries
- Post approval safety studies
- Phase IV and Phase III low intervention studies
- Health economic and outcomes studies
- Managed access and expanded access programmes, named patient programmes
- Decentralised trials
Therapeutic areas
Baseline Plus can be configured to meet the needs of many different therapeutic areas. Cisiv has supported diverse studies ranging from oncology, dermatology, neurology, pain, rare diseases, MSK, rheumatology, infectious diseases, immune-system disease, vaccines, cardiovascular diseases and others.
To learn more about how we partner contact us here.
To read our case studies click here.
Why partner with us?
Cisiv’s platform, Baseline Plus was built specifically for pharmaceutical companies to run post-approval and non-interventional studies directly. Equally, we can worth with your CRO or service provider of choice.
Baseline Plus is designed with multilingual support and has a clean and simple data entry process that is not based around a traditional e-clinical model but matches the working practice of physicians who are often research naive. Features are built in to support user communities, local variations and sharing of study outputs.
